GESVAL S.A.
Overview
GESVAL S.A. is a technology transfer and investment company established by the University of Liège and Liège University Hospital. Its mission is to manage and commercialize the intellectual property resulting from research conducted at these institutions. This involves licensing technologies to existing companies or creating spin-offs and start-ups based on university research. GESVAL S.A. manages approximately one hundred patent families and holds shares in around fifty spin-off companies on behalf of the University of Liège and Liège University Hospital. The company is also involved in managing certain major research projects for international companies. The capital of GESVAL S.A. (€8 million) is held by the University of Liège and Liège University Hospital. The board of directors is chaired by the rector of the University of Liège. GESVAL S.A. operates in the fields of technology transfer, venture capital, intellectual property management, start-ups, and spin-off companies. It focuses on early-stage investments, particularly in seed and growth stages, and is primarily active in Belgium. The company's activities include licensing technologies to existing companies and creating spin-offs and start-ups based on university research. GESVAL S.A. manages approximately one hundred patent families and holds shares in around fifty spin-off companies on behalf of the University of Liège and Liège University Hospital. The company is also involved in managing certain major research projects for international companies. The capital of GESVAL S.A. (€8 million) is held by the University of Liège and Liège University Hospital. The board of directors is chaired by the rector of the University of Liège. GESVAL S.A. operates in the fields of technology transfer, venture capital, intellectual property management, start-ups, and spin-off companies. It focuses on early-stage investments, particularly in seed and growth stages, and is primarily active in Belgium. The company's activities include licensing technologies to existing companies and creating spin-offs and start-ups based on university research. GESVAL S.A. manages approximately one hundred patent families and holds shares in around fifty spin-off companies on behalf of the University of Liège and Liège University Hospital. The company is also involved in managing certain major research projects for international companies. The capital of GESVAL S.A. (€8 million) is held by the University of Liège and Liège University Hospital. The board of directors is chaired by the rector of the University of Liège.
Investment Focus
- Innovative technologies
- University research outcomes
- Early-stage companies
- Spin-offs
- Start-ups
Reach GESVAL S.A. directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about GESVAL S.A.
What sectors does GESVAL S.A. invest in?
GESVAL S.A. invests in Venture Capital, Start-ups, Technology Transfer, Intellectual Property Management and Spin-off Companies, and is based in Wallonia, Belgium. GESVAL S.A. is listed as a other in the ConnectSafely investor database.
What stage does GESVAL S.A. invest at?
GESVAL S.A. backs companies at Seed, Early Stage and Growth.
Which regions does GESVAL S.A. invest in?
GESVAL S.A. invests across Belgium.
Last updated · Source: ConnectSafely investor database
